Background: Delays in initiating elective inpatient chemotherapy can decrease patient satisfaction and increase length of stay. At our institution, we observed that 86% of patients admitted for elective chemotherapy experienced a delay (greater than 6 hours) with a median time to chemotherapy of 18.9 hours. We developed a process improvement initiative to improve time to chemotherapy for elective chemotherapy admissions.
Methods: Our outcome measure was time from admission to chemotherapy administration in patients admitted for elective chemotherapy. Process measures were identified and monitored. We collected baseline data and utilized performance improvement tools to identify key drivers. We focused on these key drivers to develop multiple plan-do-study-act (PDSA) cycles to improve our outcome measure. Once we started an intervention we collected data every two weeks to assess our intervention.
Results: At the time of interim analysis, we observed a median decrease in time to chemotherapy administration from 18.9 hours to 8.85 hours (p value:0.005). Median time to lab resulted decreased from 3.17 hours to 0.00 hours. There was no change in time from signature to nurse releasing the chemotherapy. We noticed more providers were signing the chemotherapy prior to patient admission.
Conclusions: By implementing new admission workflows, optimizing our use of the Electronic Medical Record to communicate among providers, and improving pre-admission planning we were able to reduce our median time to chemotherapy for elective admissions by 53.2%. Improvement still needed to meet our goals and to ensure sustainability of these ongoing efforts
Adherence to US Preventative Services Task Force (USPSTF) cancer screening guidelines remains considerably lower than the recommendation of the Healthy People 2020 initiative. Patient populations recommended for screening are not screened at an appropriate rate, and populations not recommended for screening are inappropriately screened. Closer adherence to guidelines should improve outcomes and reduce costs, estimated to reach 158billion/yearby2020.Weevaluatedwhetherauseoflow−costeducationalhealthmaintenance(HM)cardbymedicalresidentsatauniversityhospitalcouldimpacteducationandadherencetoupdatedcancerscreeningguidelines.Wealsoanalyzedsavingstothehealthcaresystem.Adherencetocervical,breast,andcolorectalcancerscreeningguidelines,definedaspercentagethatwasscreened(ornotscreened)inaccordancewiththeUSPSTFguidelines,inclinicvisitsfromDecember2012(n=336)wascomparedtothosefromDecember2013(n=306)afteraqualityimprovementintervention.Post−intervention,adherencetoscreeningguidelinesincreasedby40.8998,316 (95% CI; 644,484−1,352,148). We showed a significant absolute increase in USPSTF knowledge of 28.3% irrespective of the house staff level that remained high at 2 years from the educational intervention. The low-cost HM card increased appropriate knowledgeable cancer screening adherence while reducing unnecessary testing and producing substantial savings to the healthcare system
Adherence to US Preventative Services Task Force (USPSTF) cancer screening guidelines remains considerably lower than the recommendation of the Healthy People 2020 initiative. Patient populations recommended for screening are not screened at an appropriate rate, and populations not recommended for screening are inappropriately screened. Closer adherence to guidelines should improve outcomes and reduce costs, estimated to reach 158billion/yearby2020.Weevaluatedwhetherauseoflow−costeducationalhealthmaintenance(HM)cardbymedicalresidentsatauniversityhospitalcouldimpacteducationandadherencetoupdatedcancerscreeningguidelines.Wealsoanalyzedsavingstothehealthcaresystem.Adherencetocervical,breast,andcolorectalcancerscreeningguidelines,definedaspercentagethatwasscreened(ornotscreened)inaccordancewiththeUSPSTFguidelines,inclinicvisitsfromDecember2012(n = 336)wascomparedtothosefromDecember2013(n = 306)afteraqualityimprovementintervention.Post−intervention,adherencetoscreeningguidelinesincreasedby40.8998,316 (95% CI; 644,484−1,352,148). We showed a significant absolute increase in USPSTF knowledge of 28.3% irrespective of the house staff level that remained high at 2 years from the educational intervention. The low-cost HM card increased appropriate knowledgeable cancer screening adherence while reducing unnecessary testing and producing substantial savings to the healthcare system
Infective endocarditis has different presentations depending on the involvement of valvular and perivalvular structures, and it is associated with high morbidity and mortality. Aortocavitary fistula is a rare complication. We introduce the case of a 48-year-old female with native valve endocarditis, complicated by aortocavitary fistula to the right atrium, and consequently presented with syncope